Literature DB >> 75054

Serum alphafetoprotein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovary.

A Talerman, W G Haije, L Baggerman.   

Abstract

Serum AFP was determined serially by radioimmunoassay in 13 patients with ovarian germ cell tumors and in one patient with bilateral pure gonadoblastoma. There were 4 patients with pure dysgerminoma, one with pure endodermal sinus tumor (EST) and 8 with mixed germ cell tumors, all containing EST. The patients with dysgerminoma and gonadoblastoma had normal serum AFP at all times. All patients with tumors containing EST had raised serum AFP, although in most cases it was first determined between 1 and 3 weeks after operation and there was no evidence of metastases. Serum AFP became normal 5 to 7 weeks after operation and began to rise when disease recurred. Serum AFP determinations detected presence of recurrent disease long before it became detectable by other methods. Serum CEA was determined serially by radioimmunoassay in 8 of these patients, including 2 who dies with metastases, and was normal on all occasions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75054     DOI: 10.1002/1097-0142(197801)41:1<272::aid-cncr2820410138>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?

Authors:  Amos Hong Pheng Loh; Kelvin Wai Cheak Gee; Joyce Horng Yiing Chua
Journal:  Pediatr Surg Int       Date:  2013-05-08       Impact factor: 1.827

2.  Vaginal endodermal sinus tumor.

Authors:  Vijay Kumar; Pushpa Kini; Deepti Vepakomma; M Basant
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

3.  The differential diagnosis of testicular germ cell tumors in theory and practice. A critical analysis of two major systems of classifiction and review of 389 cases.

Authors:  A R von Hochstetter; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

4.  Primary omental yolk sac tumor.

Authors:  Seon Hwa Lim; Yon Hee Kim; Ga Won Yim; Eun Ji Nam; Young Tae Kim; Sunghoon Kim
Journal:  Obstet Gynecol Sci       Date:  2013-11-15

5.  Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody.

Authors:  C Y Lee; K W Chen; F S Sheu; A Tsang; K C Chao; H T Ng
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Prognostic value of serum α-fetoprotein in ovarian yolk sac tumors: A systematic review and meta-analysis.

Authors:  Yang-Long Guo; Ying-Li Zhang; Jian-Qing Zhu
Journal:  Mol Clin Oncol       Date:  2014-09-18

7.  Alpha-fetoprotein, alpha-1-antitrypsin, and transferrin in gonadal yolk-sac tumours.

Authors:  J O Beilby; C H Horne; G D Milne; C Parkinson
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411

8.  Serum levels of six tumor markers in patients with benign and malignant gynecological disease.

Authors:  I Fukazawa; N Inaba; Y Ota; N Sato; S Shirotake; H Iwasawa; T Sato; H Takamizawa; B Wiklund
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

9.  Giving Birth After Fertility Sparing Treatment for a Yolk Sac Tumour: Case Report.

Authors:  Georgios-Marios Makris; Alexandros Fotiou; Georgios Chrelias; Marco-Johannes Battista; Charalampos Chrelias
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 10.  Pure yolk sac tumor of sacrococcygeal region.

Authors:  Rashim Sharma; Sudeep Khera; Arvind Sinha; Taruna Yadav
Journal:  Autops Case Rep       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.